Le Lézard
Classified in: Health, Science and technology, Business
Subjects: TDS, LIC

Tausight Features Patient Data Protection at HIMSS 2024


Collaboration with Dell Technologies provides healthcare organizations with improved visibility and protection of sensitive patient data

BOSTON, March 11, 2024 /PRNewswire/ -- Tausight, the leader in patient data protection, today announced a collaboration with Dell Technologies to advance cybersecurity for the healthcare industry with a solution that gives healthcare organizations tools to monitor and protect their most sensitive data.

"We're proud to collaborate with Dell to give healthcare organizations immediate visibility and insight into sensitive data so they can detect, track, and respond to any activity," said David Ting, Founder and Chief Technology Officer at Tausight. "Customers will have the ability to scan and secure sensitive data across their entire infrastructure, which will help combat the cyber threat crisis in healthcare."

Customers that leverage Dell for their backup and recovery, a critical part of any cyber strategy, will now be able to easily scan their infrastructure for sensitive data, and ensure it is properly archived in air-gapped storage. This improves preparedness in the event of a cyberattack that results in encrypted or lost data. Clinicians using Dell PCs powered by Tausight Patient Data Protectiontm will have live monitoring of sensitive data on their endpoints fed directly to IT and security teams so that anomalies or suspicious activity can be reviewed and remediated.

Learn more about the Tausight-Dell relationship featured at the HIMSS 2024 Dell Booth #2560, taking place March 11-14 in Orlando, FL.

About Tausight
Tausight is healthcare's first AI-powered ePHI security company with a vision of reducing healthcare-specific cybersecurity incidents by leveraging the power of AI to detect and manage PHI risk in today's decentralized healthcare ecosystems. Founded in 2018 by healthcare security pioneer David Ting and led by healthcare visionary Frank Nydam, Tausight is backed by top-tier healthcare investors Polaris PartnersFlare Capital Partners, .406 Ventures and SpringRock Ventures,  and is based in Boston, Massachusetts. For more information, visit: www.tausight.com and follow us on LinkedIn and Twitter (@Tausight).

SOURCE Tausight


These press releases may also interest you

at 08:20
Merck , known as MSD outside of the United States and Canada, and Orion Corporation ("Orion") today announced that notice has been provided of the mutual exercise of an option to convert the companies' ongoing co-development and co-commercialization...

at 08:20
Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, filed a lawsuit asserting multiple claims for damages against Exact Sciences on June 28, 2024, in federal court in the...

at 08:17
After rocketing to success across social media, boohoo announced The boohoo Collective; an initiative redefining social commerce by integrating 1000s of creators into the shopping experience on boohoo.com. The initiative gives any creator a personal...

at 08:15
Masimo Corporation ("Masimo" or the "Company") today issued a letter to stockholders in connection with the Company's 2024 Annual Meeting of Stockholders. The letter highlights the fierce independence and deep medtech experience of nominee...

at 08:15
Following the CEO transition plan previously announced by Bentley Systems, Incorporated , Nicholas Cumins today takes charge as CEO. Cumins succeeds Greg Bentley, the eldest of the five brothers who founded Bentley Systems, who becomes Executive...

at 08:15
KaliVir Immunotherapeutics, Inc., a biotech company developing cutting-edge, multi-mechanistic oncolytic viral immunotherapy programs, today announced that the FDA has cleared the Investigational New Drug (IND) application for the STEALTH-001 study...



News published on and distributed by: